BioAtla (BCAB) Treasury Shares (2020 - 2026)
BioAtla (BCAB) posted quarterly Treasury Shares of $59740.0 for Q1 2026, down 97.95% year-over-year from $2.9 million in Q1 2025, and up 22.73% quarter-over-quarter from $48676.0 in Q4 2025.
BioAtla (BCAB) Treasury Shares (2020 - 2026) Analysis & Trends
BioAtla's Treasury Shares history runs 7 years deep, the most recent figure standing at $59740.0 for Q1 2026.
- In Q1 2026, Treasury Shares fell 97.95% year-over-year to $59740.0; the TTM figure through Mar 2026 stood at $59740.0 (down 97.95% YoY), while the FY2025 annual figure was $48676.0, down 96.87% from the prior year.
- Treasury Shares for Q1 2026 stood at $59740.0, up from $48676.0 in the prior quarter.
- The five-year high for Treasury Shares was $2.9 million in Q1 2025, with the low at $48676.0 in Q4 2025.
- The 5-year median for Treasury Shares is $739959.0 (2022), against an average of $1.1 million.
- The sharpest annual moves came in 2024 and 2026: Treasury Shares soared 1467.04% in 2024, then sank 97.95% in 2026.
- BioAtla's Treasury Shares stood at $510039.0 in 2022, then sank by 80.57% to $99104.0 in 2023, then jumped by 1467.04% to $1.6 million in 2024, then slumped by 96.87% to $48676.0 in 2025, then increased by 22.73% to $59740.0 in 2026.
- Business Quant data shows BCAB's Treasury Shares at $59740.0 in Q1 2026, $48676.0 in Q4 2025, and $2.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 36.40 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 8.96 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 2.72 Mn |
| 10 | BioAtla | 5.41 Mn | 5.41 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 57,404.00 |
| Jun 30, 2026 | 57,404.00 |
| Mar 31, 2026 | 59,740.00 |
| Mar 31, 2026 | 59,740.00 |
| Dec 31, 2025 | 48,676.00 |
| Dec 31, 2025 | 48,676.00 |
| Sep 30, 2025 | 2.52 Mn |
| Sep 30, 2025 | 2.52 Mn |
| Jun 30, 2025 | 2.61 Mn |
| Jun 30, 2025 | 2.61 Mn |
| Mar 31, 2025 | 2.91 Mn |
| Mar 31, 2025 | 2.91 Mn |
| Dec 31, 2024 | 1.55 Mn |
| Dec 31, 2024 | 1.55 Mn |
| Sep 30, 2024 | 1.57 Mn |
| Sep 30, 2024 | 1.57 Mn |
| Jun 30, 2024 | 1.61 Mn |
| Jun 30, 2024 | 1.61 Mn |
| Mar 31, 2024 | 1.56 Mn |
| Mar 31, 2024 | 1.56 Mn |